These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1831083)

  • 1. Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers.
    Burnier M; Ganslmayer M; Perret F; Porchet M; Kosoglou T; Gould A; Nussberger J; Waeber B; Brunner HR
    Clin Pharmacol Ther; 1991 Aug; 50(2):181-91. PubMed ID: 1831083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
    J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.
    Sybertz EJ; Chiu PJ; Vemulapalli S; Watkins R; Haslanger MF
    Hypertension; 1990 Feb; 15(2):152-61. PubMed ID: 2154404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats.
    Vemulapalli S; Chiu PJ; Brown A; Griscti K; Sybertz EJ
    Life Sci; 1991; 49(5):383-91. PubMed ID: 1649942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
    Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.
    Sybertz EJ; Chiu PJ; Watkins RW; Vemulapalli S
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1628-35. PubMed ID: 1838029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
    Tikkanen I; Helin K; Tikkanen T; Sybertz EJ; Vemulapalli S; Sariola H; Näveri H; Fyhrquist F
    J Pharmacol Exp Ther; 1990 Aug; 254(2):641-5. PubMed ID: 2143536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent neutral endopeptidase and ACE inhibition in experimental heart failure: renal and hormonal effects.
    Helin K
    Scand J Clin Lab Invest; 1993 Dec; 53(8):843-51. PubMed ID: 8140395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and hormonal effects of neutral endopeptidase inhibitor SCH 39370 in sheep.
    Charles CJ; Espiner EA; Cameron VA; Richards AM; Yandle TG; Sybertz EJ
    Hypertension; 1991 May; 17(5):643-51. PubMed ID: 1850715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and humoral effects of chronic treatment with the neutral endopeptidase inhibitor SCH 42495 in spontaneously hypertensive rats.
    Sala C; Monopoli A; Casati C; Ardeleani G; Ongini E; Zanchetti A; Morganti A
    J Cardiovasc Pharmacol; 1994 May; 23(5):703-8. PubMed ID: 7521451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension.
    Singer DR; Markandu ND; Buckley MG; Miller MA; Sagnella GA; MacGregor GA
    Hypertension; 1991 Dec; 18(6):798-804. PubMed ID: 1835959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
    Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
    Sybertz EJ; Chiu PJ; Vemulapalli S; Pitts B; Foster CJ; Watkins RW; Barnett A; Haslanger MF
    J Pharmacol Exp Ther; 1989 Aug; 250(2):624-31. PubMed ID: 2547941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitor.
    Watkins RW; Vemulapalli S; Chiu PJ; Foster C; Smith EM; Neustadt B; Haslanger M; Sybertz EJ
    Am J Hypertens; 1993 May; 6(5 Pt 1):357-68. PubMed ID: 8512660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is atrial natriuretic peptide-guanosine 3',5' cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension?
    Sagnella GA; Singer DR; Markandu ND; Buckley MG; MacGregor GA
    J Hypertens; 1992 Apr; 10(4):349-54. PubMed ID: 1316400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the metabolism of atrial natriuretic factor causes diuresis and natriuresis in chronic heart failure.
    Northridge DB; Jardine AG; Findlay IN; Archibald M; Dilly SG; Dargie HJ
    Am J Hypertens; 1990 Sep; 3(9):682-7. PubMed ID: 2145874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension.
    O'Connell JE; Jardine AG; Davidson G; Connell JM
    J Hypertens; 1992 Mar; 10(3):271-7. PubMed ID: 1315825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neutral endopeptidase inhibition in the rat remnant kidney model.
    Jandeleit-Dahm K; Burrell LM; Kanazawa M; Casley D; Jackson B; Johnston CI
    Kidney Blood Press Res; 1998; 21(6):419-24. PubMed ID: 9933826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.